These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8357631)

  • 1. [Epidemiologic aspects of cancer of the nasopharyngeal cavum].
    García-Purriños F; Díaz González MP; del Cañizo A; Muñoz Herrera A
    Acta Otorrinolaringol Esp; 1993; 44(3):191-5. PubMed ID: 8357631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experience with cancer of the cavum in Murcia].
    Rosique Arias M; Hellín Meseguer D; Merino Gálvez E; Manuel Mondéjar J; Escobar Sánchez C
    Acta Otorrinolaringol Esp; 1989; 40(6):425-7. PubMed ID: 2631913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Incidence of nasopharyngeal cancer in La Rioja (Spain). Epidemiological aspects].
    Sánchez Galán L; Sánchez del Hoyo A; Erdozain Rodríguez I; Zabaleta López M; García Cano J
    Acta Otorrinolaringol Esp; 1997 Apr; 48(3):199-203. PubMed ID: 9235033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective cohort study of nasopharyngeal adenocarcinoma: a rare histological type of nasopharyngeal cancer.
    Guo ZM; Liu WW; He JH
    Clin Otolaryngol; 2009 Aug; 34(4):322-7. PubMed ID: 19673979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical presentation of patients with nasopharyngeal carcinoma.
    Suzina SA; Hamzah M
    Med J Malaysia; 2003 Oct; 58(4):539-45. PubMed ID: 15190630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comorbidity in nasopharyngeal carcinoma: a preliminary communication on the prevalence, descriptive distribution and impact on outcome.
    Ramakrishnan Y; Paleri V; Shah R; Steen IN; Wight RG; Kelly CG
    Clin Otolaryngol; 2007 Dec; 32(6):484-8. PubMed ID: 18076440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer of the nasopharynx--a review of 1036 cases seen at the Tata Memorial Hospital, Bombay, India.
    Sawai MM; Talwalkar GV; Gangadharan P
    Indian J Cancer; 1983; 20(2):89-96. PubMed ID: 6642549
    [No Abstract]   [Full Text] [Related]  

  • 8. Nasopharyngeal cancer in a low-risk population: defining risk factors by histological type.
    Vaughan TL; Shapiro JA; Burt RD; Swanson GM; Berwick M; Lynch CF; Lyon JL
    Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):587-93. PubMed ID: 8824359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Epidemiologic approach to cancer of the nasopharynx in Morocco].
    el Gueddari B; Kahlain A; Iraqi A; Tazi H; Sqalli S; Salmi M
    Maghrib Tibbi; 1984 Dec; 6(4):297-305. PubMed ID: 6535896
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of malignant nasopharyngeal tumors].
    Suzuki Y; Miyake H; Inuyama Y; Araki A; Takasaki K
    Nihon Jibiinkoka Gakkai Kaiho; 1970 Jul; 73(7):859-70. PubMed ID: 5465902
    [No Abstract]   [Full Text] [Related]  

  • 11. [Statistical survey on nasopharyngeal tumors--a study with reference to early diagnosis].
    Sato F
    Nihon Jibiinkoka Gakkai Kaiho; 1970 Oct; 73(10):1620-33. PubMed ID: 5529345
    [No Abstract]   [Full Text] [Related]  

  • 12. Survival study and treatment strategy for second primary malignancies in patients with head and neck squamous cell carcinoma and nasopharyngeal carcinoma.
    Tsou YA; Hua CH; Tseng HC; Lin MH; Tsai MH
    Acta Otolaryngol; 2007 Jun; 127(6):651-7. PubMed ID: 17503236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasopharyngeal cancer incidence and survival in Scotland, 1975-2001.
    Anandan C; Elton R; Hitchings A; Brewster DH
    Clin Otolaryngol; 2008 Feb; 33(1):12-7. PubMed ID: 18302545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nasopharyngeal Carcinoma Database.
    Pua KC; Khoo AS; Yap YY; Subramaniam SK; Ong CA; Gopala Krishnan G; Shahid H;
    Med J Malaysia; 2008 Sep; 63 Suppl C():59-62. PubMed ID: 19230249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicity and compliance with a chemoradiotherapy schedule for advanced nasopharyngeal carcinoma: a single institution experience using the Intergroup 0099 study regimen.
    Chajón EA; García-Berrocal MI; De la Fuente C; Regueiro C; Romero J; Valcárcel F; Magallón R; Hernanz R; De la Torre A
    Acta Oncol; 2005; 44(1):85-6. PubMed ID: 15848912
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment outcome and prognosis of 112 patients with nasal and nasopharyngeal peripheral T cell lymphomas].
    Zhang YJ; Ren ZM; Wu QL; He ZY; Huang Y; Xia YF; Lin TY; Cui NJ
    Zhonghua Xue Ye Xue Za Zhi; 2006 Apr; 27(4):217-21. PubMed ID: 16875549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant tumours of the nasopharynx at Jos University Teaching Hospital, Nigeria.
    da Lilly-Tariah OB; Somefun AO
    Niger Postgrad Med J; 2003 Jun; 10(2):99-102. PubMed ID: 14567045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety.
    Wee J; Tan EH; Tai BC; Wong HB; Leong SS; Tan T; Chua ET; Yang E; Lee KM; Fong KW; Tan HS; Lee KS; Loong S; Sethi V; Chua EJ; Machin D
    J Clin Oncol; 2005 Sep; 23(27):6730-8. PubMed ID: 16170180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical presentation of nasopharyngeal carcinoma in Sarawak Malaysia.
    Tiong TS; Selva KS
    Med J Malaysia; 2005 Dec; 60(5):624-8. PubMed ID: 16515114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Difference in the incidence trend of nasopharyngeal and oropharyngeal carcinomas in Taiwan: implication from age-period-cohort analysis.
    Hsu C; Shen YC; Cheng CC; Hong RL; Chang CJ; Cheng AL
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):856-61. PubMed ID: 16702360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.